Search research articles
Contact Us
Filters
Showing results (111-120 of 217) with videos related to
Page
of 22
Sort By:
Cardiovascular Ultrasound
|
November 10, 2021
2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab
Nathalie I Bouwer, Crista Liesting, Marcel J M Kofflard, et al.
Environmental Science and Pollution Research International
|
December 9, 2025
Nature-inspired biodegradation of poly(butylene succinate-co-adipate): the potential of Cladosporium psychrotolerans isolated from marine copepods
Luca Niccolini, Giampiero De Simone, Maurizia Seggiani, et al.
Blood Cancer Journal
|
January 6, 2025
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
Paul J Hengeveld, Joyce Schilperoord-Vermeulen, P Martijn Kolijn, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 4, 2017
Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands
Sabina Kersting, Suzanne I M Neppelenbroek, Hein P J Visser, et al.
Blood Cancer Journal
|
January 12, 2023
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, et al.
Leukemia & Lymphoma
|
September 1, 2020
Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib
Rebecka Svanberg, Sisse Rye Ostrowski, Kazem Nasserinejad, et al.
The Oncologist
|
July 21, 2022
Association Between Geriatric Assessment and Post-Chemotherapy Functional Status in Older Patients with Cancer
Hánah N Rier, Marieke C Meinardi, Joost van Rosmalen, et al.
Hemasphere
|
November 13, 2024
Causes of death among patients diagnosed with chronic lymphocytic leukemia: A population-based study in the Netherlands, 1996-2020
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, et al.
Haematologica
|
March 23, 2023
High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population
Camille C B Kockerols, Inge G P Geelen, Mark-David Levin, et al.
Cardio-Oncology (London, England)
|
March 11, 2020
NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab
Nathalie I Bouwer, Crista Liesting, Marcel J M Kofflard, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 217) with videos related to
Sort By:
Page
of 22
Cardiovascular Ultrasound
|
November 10, 2021
2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab
Nathalie I Bouwer, Crista Liesting, Marcel J M Kofflard, et al.
Environmental Science and Pollution Research International
|
December 9, 2025
Nature-inspired biodegradation of poly(butylene succinate-co-adipate): the potential of Cladosporium psychrotolerans isolated from marine copepods
Luca Niccolini, Giampiero De Simone, Maurizia Seggiani, et al.
Blood Cancer Journal
|
January 6, 2025
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
Paul J Hengeveld, Joyce Schilperoord-Vermeulen, P Martijn Kolijn, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 4, 2017
Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands
Sabina Kersting, Suzanne I M Neppelenbroek, Hein P J Visser, et al.
Blood Cancer Journal
|
January 12, 2023
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, et al.
Leukemia & Lymphoma
|
September 1, 2020
Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib
Rebecka Svanberg, Sisse Rye Ostrowski, Kazem Nasserinejad, et al.
The Oncologist
|
July 21, 2022
Association Between Geriatric Assessment and Post-Chemotherapy Functional Status in Older Patients with Cancer
Hánah N Rier, Marieke C Meinardi, Joost van Rosmalen, et al.
Hemasphere
|
November 13, 2024
Causes of death among patients diagnosed with chronic lymphocytic leukemia: A population-based study in the Netherlands, 1996-2020
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, et al.
Haematologica
|
March 23, 2023
High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population
Camille C B Kockerols, Inge G P Geelen, Mark-David Levin, et al.
Cardio-Oncology (London, England)
|
March 11, 2020
NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab
Nathalie I Bouwer, Crista Liesting, Marcel J M Kofflard, et al.
Page
of 22